Innovating Clinical Trials

By: Liam Eves and Ted Trafford
  • Summary

  • Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    Ted Trafford - https://traffordresearch.com/
    With 29 years of experience in clinical research, Ted leads Feasibility, Business Development, and Site Relationship teams as Director of Business Development at Probity Medical Research, a clinical trial site administrative support company with a consortium of 70 sites across four countries. As a writer, advisor and speaker, Ted contributes to thought leadership and strategic initiatives in the clinical trials industry, leveraging his extensive experience and creative approach to drive meaningful discussion and progress for Sponsors, CROs, Sites and Technology Vendors.

    Liam Eves - https://www.theendpointpodcast.com/
    Liam's held executive roles in SMOs and CROs, and led all major functions of trial delivery. His journey into the field began unexpectedly after an injury ended his career as a professional footballer. Over the years Liam has optimized trial delivery methods / systems for effective enrollment and trial delivery. Currently, he focuses on building and advising companies in the clinical trial space.

    © 2024 Innovating Clinical Trials
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
activate_samplebutton_t1
Episodes
  • ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 3 of 3)
    Sep 8 2024

    Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.

    Show More Show Less
    18 mins
  • ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 2 of 3)
    Sep 8 2024

    Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In this session we continue our discussion with Joel White from Marketcap Consulting about the financial performance of the clinical development space. We find out what Joel is bullish about and dive into the pre-clinical space.

    Stay tuned for part 3.

    Show More Show Less
    16 mins
  • ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 1 of 3)
    Sep 8 2024

    Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. We discuss Joel's start in the industry, his thoughts on the macro trends and some of the challenges with technology.

    Stay tuned for part 2 and 3.



    Show More Show Less
    15 mins

What listeners say about Innovating Clinical Trials

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.